Bad Neuenahr-Ahrweiler, Germany

Elke Klein

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Elke Klein

Introduction

Elke Klein is a notable inventor based in Bad Neuenahr-Ahrweiler, Germany. She has made significant contributions to the field of transdermal therapeutic systems, holding a total of five patents. Her work focuses on the transdermal administration of guanfacine, a medication used to treat various conditions.

Latest Patents

Among her latest patents is a transdermal therapeutic system for the transdermal administration of guanfacine, which includes at least one additive. This invention features a guanfacine-containing layer structure that comprises a backing layer and a guanfacine-containing layer. The system is designed to enhance the delivery of guanfacine through the skin. Another notable patent involves a similar transdermal therapeutic system that utilizes a silicone polymer in its formulation. This innovation also includes a guanfacine-containing layer structure, showcasing her commitment to improving medication delivery methods.

Career Highlights

Throughout her career, Elke Klein has worked with prominent companies such as LTS Lohmann Therapie-Systeme AG and DDP Specialty Electronic Materials US 9, LLC. Her experience in these organizations has contributed to her expertise in developing advanced therapeutic systems.

Collaborations

She has collaborated with talented individuals in her field, including Marco Emgenbroich and Heike Kluth. These partnerships have likely enriched her work and led to innovative solutions in transdermal therapy.

Conclusion

Elke Klein's contributions to the field of transdermal therapeutic systems highlight her innovative spirit and dedication to improving healthcare solutions. Her patents reflect her expertise and commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…